Introducing the first FDA approved rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen. This 4th generation test has the ability to identify HIV earlier than 2nd and 3rd generation antibody-only tests.1 It enables health care providers to diagnose HIV infection earlier allowing individuals to seek medical care sooner.
Now CLIA-Waived for fingerstick whole blood!
Only available in the US.
CLIA-waived for fingerstick whole blood
It’s the first 4th generation rapid point-of-care test that detects both HIV-1/2 antibodies and free HIV-1 p24 antigen on a single test strip.
Built-in quality controls to let you know the test is working.
Test in three simple steps with clear results in just 20 minutes.
A 4th generation test, with the ability to detect HIV earlier than 2nd and 3rd generation antibody-only tests.1
Test using whole blood, serum or plasma samples.
Proved 99.9% overall clinical sensitivity for all sample types.